Glenmark Pharmaceuticals gains on reporting 8-fold rise in Q3 net profit

30 Jan 2013 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 513.80, up by 9.75 points or 1.93% from its previous closing of Rs. 504.05 on the BSE.

The scrip opened at Rs. 515.00 and has touched a high and low of Rs. 529.00 and Rs. 512.00 respectively. So far 69,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 550.80 and a 52 week low of Rs. 286.15.

The current market cap of the company is Rs. 13,910.00 crore.

The promoters holding in the company stood at 48.32% while Institutions and Non-Institutions held 40.01% and 11.67% respectively.

The company has posted over 8-fold rise its net profit at Rs 109.03 crore for third quarter ended December 31, 2012 as compared to Rs 13.14 crore for the same quarter in the previous year. Total income of the company has increased by 35.18% at Rs 555.94 crore for quarter under review as compared to Rs 411.25 crore for the quarter ended December 31, 2011.

On consolidated basis, the company has posted over 5-fold rise its net profit at  Rs 212.91 crore for the quarter ended December 31, 2012 as compared to Rs 44.82 crore for the same quarter in the previous year. Total income of the company has increased by 33.08% at Rs 1386.76 crore for quarter under review as compared to Rs 1042.06 crore for the quarter ended December 31, 2011.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×